Literature DB >> 20336221

Is cytochrome modulation the new frontier for decreasing the risk of cataract?

Kavitha S Nair1, Kirti V Patel, Tejal R Gandhi.   

Abstract

AIM: The present study was designed to study the effect of cytochrome P450 (CYP) modulators on the occurrence of cataract using male Sprague-Dawley rats weighing 40:50 gm.
MATERIALS AND METHODS: Macroscopical examination of the lens isolated from rats pretreated with diltiazem (30 mg/kg; once daily; PO) showed delayed occurrence of cataract while pioglitazone (3.8 mg/kg; once daily; PO) pretreatment demonstrated an early cataract. RESULTS AND
CONCLUSION: A delayed occurrence of cataract with diltiazem (CYP inhibitor) and an early onset of cataract with pioglitazone (CYP inducer) indicate that a cytochrome P450 mediated pathway may affect the initiation of cataract but not the maturation pattern.

Entities:  

Keywords:  Cataract; cytochrome P450; diltiazem; pioglitazone

Year:  2009        PMID: 20336221      PMCID: PMC2841236          DOI: 10.4103/0253-7613.51344

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   1.200


  7 in total

1.  Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

Authors:  A J Krentz; C J Bailey; A Melander
Journal:  BMJ       Date:  2000-07-29

2.  THE EFFECT OF DIABETES ON THE CONTENT OF SORBITOL, GLUCOSE, FRUCTOSE AND INOSITOL IN THE HUMAN LENS.

Authors:  A PIRIE; R VANHEYNINGEN
Journal:  Exp Eye Res       Date:  1964-06       Impact factor: 3.467

3.  Vision 2020: the cataract challenge.

Authors: 
Journal:  Community Eye Health       Date:  2000

4.  Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.

Authors:  B Ma; T Prueksaritanont; J H Lin
Journal:  Drug Metab Dispos       Date:  2000-02       Impact factor: 3.922

Review 5.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

6.  Cataracts in galactosemia. The Jonas S. Friedenwald Memorial Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1965-10

7.  Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.

Authors:  S M Lee; S Z Schade; C C Doughty
Journal:  Biochim Biophys Acta       Date:  1985-09-06
  7 in total
  5 in total

1.  Role of Cytochrome Modulators in Altering the Occurrence of Cataract in Rats.

Authors:  Kanchan Gupta; Shivani Juneja; G S Bajwa; Sandeep Kaushal
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Is cytochrome modulation the new frontier for decreasing the risk of cataract?

Authors: 
Journal:  Indian J Pharmacol       Date:  2009-12       Impact factor: 1.200

3.  Cytochrome modulation decreases the risk of cataract: Is the basic hypothesis flawless?

Authors:  Rajiv Mahajan; Kapil Gupta
Journal:  Indian J Pharmacol       Date:  2009-10       Impact factor: 1.200

4.  Effect of rifampicin and erythromycin on the initiation of galactose induced cataract in rats.

Authors:  Raj Rajeshwari R Patil; Pratibha S Worlikar; Amol B Chaudhari; Ozhukil K Radhakrishnan; Rajendra P Gupta; Saurabh Puri
Journal:  J Pharmacol Pharmacother       Date:  2012-10

5.  Patterns of gene expression in microarrays and expressed sequence tags from normal and cataractous lenses.

Authors:  Konstantinos Sousounis; Panagiotis A Tsonis
Journal:  Hum Genomics       Date:  2012-09-01       Impact factor: 4.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.